Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo
Clinical trial NCT00258310 · COMPLETED
Trial details
- NCT number
- NCT00258310
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.